Literature DB >> 22903714

Glycoproteins and glycosylation: apolipoprotein c3 glycoforms by top-down maldi-tof mass spectrometry.

Yan Zhang1, Alan R Sinaiko, Gary L Nelsestuen.   

Abstract

Apolipoprotein C3 (ApoC3) is synthesized in liver so that levels or isoform distributions may constitute indicators of liver pathogenesis. The glycoforms of intact protein ApoC3 in serum or plasma can be readily analyzed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry after a one-step extraction using a C4 reverse-phase ZipTip. Glycoform distributions were sensitive to severe systemic diseases such as sepsis or liver diseases such as chronic hepatitis C and alcoholic liver cirrhosis. Glycoisoform distributions were also altered in persons with elevated body mass index and were corrected to normal distribution by metformin, a common drug used for diabetes therapy. This simple method may offer an approach to analysis of health and the mechanism of drug therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903714     DOI: 10.1007/978-1-61779-959-4_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Top-down tandem mass spectrometry on RNase A and B using a Qh/FT-ICR hybrid mass spectrometer.

Authors:  Sandrine Bourgoin-Voillard; Nancy Leymarie; Catherine E Costello
Journal:  Proteomics       Date:  2014-04-24       Impact factor: 3.984

2.  New Interface for Faster Proteoform Analysis: Immunoprecipitation Coupled with SampleStream-Mass Spectrometry.

Authors:  Henrique Dos Santos Seckler; Hae-Min Park; Cameron M Lloyd-Jones; Rafael D Melani; Jeannie M Camarillo; John T Wilkins; Philip D Compton; Neil L Kelleher
Journal:  J Am Soc Mass Spectrom       Date:  2021-05-27       Impact factor: 3.262

3.  Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study.

Authors:  John T Wilkins; Henrique S Seckler; Jonathan Rink; Philip D Compton; Luca Fornelli; C Shad Thaxton; Rich LeDuc; David Jacobs; Peter F Doubleday; Allan Sniderman; Donald M Lloyd-Jones; Neil L Kelleher
Journal:  J Am Heart Assoc       Date:  2021-09-02       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.